Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Minerva Neurosciences, Inc (NERV) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.26M |
|
-- |
|
-- |
|
$3.37M |
|
$-3.37M |
|
$0.12M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.37M |
|
$-3.37M |
|
7.57M |
|
7.57M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$15.55M |
|
$0.00M |
|
$14.87M |
|
$30.42M |
|
$2.53M |
|
-- |
|
$60.00M |
|
$62.53M |
|
$-32.11M |
|
$-46.98M |
|
$-32.11M |
|
6.99M |
|
| Cash Flow Statement Financials | |
$-6.11M |
|
-- |
|
-- |
|
$21.46M |
|
$15.35M |
|
$-6.11M |
|
$0.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.15 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.15% |
|
6.94% |
|
-10.71% |
|
10.15% |
|
$-4.59 |
|
$-0.81 |
|
$-0.81 |
|